Top Markets
Coin of the day
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rang in Aktien #1816
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Aktienkurs
$334.75
Zuletzt synchronisiert: 2024-05-30
Marktkapitalisierung
$12.46B
Veränderung (1 Tag)
-0.02%
Veränderung (1 Jahr)
0.00%
Land
US
Handel ShockWave Medical, Inc. (SWAV)

Kategorie

P/B-Verhältnis für ShockWave Medical, Inc. (SWAV)
P/B-Verhältnis zum August 2026 TTM: 18.38
Laut den neuesten Finanzberichten und dem Aktienkurs von ShockWave Medical, Inc. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 18.38. Am Ende des Jahres 2022 lag das P/B-Verhältnis bei 14.44.
P/B-Verlauf für ShockWave Medical, Inc. von 2017 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
2026 (TTM) 18.38 75.67%
2023 10.46 -27.54%
2022 14.44 -44.22%
2021 25.88 70.18%
2020 15.21 179.07%
2019 5.45 -79.73%
2018 26.88 -475.89%
2017 -7.15 0.00%
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
3.7944 -79.35%
US
5.423 -70.49%
US
2.0146 -89.04%
IE
3.072 -83.28%
US
- -
DE